DK0833649T3 - Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf - Google Patents

Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf

Info

Publication number
DK0833649T3
DK0833649T3 DK96918707T DK96918707T DK0833649T3 DK 0833649 T3 DK0833649 T3 DK 0833649T3 DK 96918707 T DK96918707 T DK 96918707T DK 96918707 T DK96918707 T DK 96918707T DK 0833649 T3 DK0833649 T3 DK 0833649T3
Authority
DK
Denmark
Prior art keywords
allergies
preparations
prevention
preparation
treatment
Prior art date
Application number
DK96918707T
Other languages
English (en)
Other versions
DK0833649T4 (da
Inventor
Erika Isolauri
Leena Metsaeniitty
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaeoja
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0833649(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Application granted granted Critical
Publication of DK0833649T3 publication Critical patent/DK0833649T3/da
Publication of DK0833649T4 publication Critical patent/DK0833649T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96918707T 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier DK0833649T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
PCT/FI1996/000350 WO1997000078A1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies

Publications (2)

Publication Number Publication Date
DK0833649T3 true DK0833649T3 (da) 2003-04-07
DK0833649T4 DK0833649T4 (da) 2009-07-20

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918707T DK0833649T4 (da) 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier

Country Status (27)

Country Link
US (2) US6506380B1 (da)
EP (1) EP0833649B2 (da)
JP (1) JP3983804B2 (da)
KR (1) KR100494741B1 (da)
CN (1) CN1154506C (da)
AR (1) AR003960A1 (da)
AT (1) ATE230606T1 (da)
BG (1) BG63153B1 (da)
BR (1) BR9607827A (da)
CA (1) CA2224320C (da)
CZ (1) CZ291904B6 (da)
DE (1) DE69625690T3 (da)
DK (1) DK0833649T4 (da)
EE (1) EE03424B1 (da)
ES (1) ES2191103T5 (da)
FI (1) FI104465B (da)
HK (1) HK1010081A1 (da)
IL (1) IL122577A0 (da)
MX (1) MX9710109A (da)
MY (1) MY113912A (da)
NO (1) NO321504B1 (da)
NZ (1) NZ310478A (da)
PL (1) PL185123B1 (da)
RO (1) RO120243B1 (da)
SK (1) SK284245B6 (da)
WO (1) WO1997000078A1 (da)
ZA (1) ZA965088B (da)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ES2317666T3 (es) * 1997-06-03 2009-04-16 Ganeden Biotech, Inc. Bacteria acida lactica probiotica para tratar infecciones bacterianas asociadas con el sids.
EP1108783A3 (en) 1999-01-19 2001-09-05 Maxygen, Inc. Oligonucleotide-mediated nucleic acid recombination
TR200200301T2 (tr) 1999-08-05 2004-12-21 Societe Des Produits Nestle S.A. Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
CN1198631C (zh) 1999-08-05 2005-04-27 雀巢制品公司 双歧杆菌在制备预防腹泻药物中的用途
AU2001234784A1 (en) * 2000-02-04 2001-08-14 Bioseek Compositions and methods for reducing autoimmunity
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
JP2004514424A (ja) * 2000-09-25 2004-05-20 ソシエテ　デ　プロデユイ　ネツスル　ソシエテ　アノニム アレルギー反応を起こす個人の傾向を減少させることができる乳酸菌
ES2357419T3 (es) * 2000-10-06 2011-04-26 Nestec S.A. Uso de bacterias probióticas productoras de ácido láctico para proteger la piel contra reacciones inflamatorias, alérgicas o inmunosupresoras causadas por la radiación ultravioleta.
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
JP4176715B2 (ja) 2002-06-28 2008-11-05 プレバ、バイオテック、ソシエダッド、アノニマ プロバイオティクス菌株、その選択方法、その組成物、およびその使用
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PT1638416E (pt) 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
BRPI0508068B1 (pt) 2004-02-25 2017-11-28 Pioneer Hi-Bred International, Inc. Molecule of nucleic acid isolated, vector understanding, polyepeptide isolated, composition understanding the same and methods of transgenic plant production and increased insect resistance in transgenic plants
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
BRPI0618569A2 (pt) * 2005-11-14 2011-09-06 Nestec Sa promoção de toleráncia oral com proteìnas glicadas
WO2007093619A1 (en) 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
MY149913A (en) 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
US20100255039A1 (en) * 2006-06-15 2010-10-07 Nestec S.A. Induction of tolerance to egg proteins
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974734A1 (en) † 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
PT2244593E (pt) 2008-01-24 2015-08-26 Nestec Sa Cápsula contendo ingredientes nutricionais e método de distribuição de um líquido nutricional a partir da cápsula
ES2585407T3 (es) 2008-02-01 2016-10-05 Murdoch Childrens Research Institute Un método para inducir tolerancia a un alérgeno
SG188887A1 (en) 2008-03-14 2013-04-30 Nestec Sa Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
EP2285958B1 (en) 2008-06-13 2016-03-09 Codexis, Inc. Method of synthesizing polynucleotide variants
US8178333B2 (en) 2008-06-24 2012-05-15 Codexis, Inc. Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8426178B2 (en) 2008-08-27 2013-04-23 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
HUE052297T2 (hu) 2009-01-08 2021-04-28 Codexis Inc Transzamináz polipeptidek
US9005946B2 (en) 2009-03-17 2015-04-14 Codexis, Inc. Variant endoglucanases and related polynucleotides
EP2414506B1 (en) 2009-03-31 2017-05-03 Codexis, Inc. Improved endoglucanases
EP2443139B1 (en) 2009-06-16 2016-08-10 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
HUE055413T2 (hu) 2009-06-22 2021-11-29 Codexis Inc Ketoreduktáz-közvetített sztereoszelektív útvonal alfa-klóralkoholokhoz
US8614081B2 (en) 2009-07-23 2013-12-24 Codexis, Inc. Nitrilase biocatalysts
US9439449B2 (en) 2009-08-18 2016-09-13 Nestec S.A. Nutritional composition comprising Bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
BR112012003706A2 (pt) * 2009-08-18 2015-09-01 Nestec Sa Composição nutritiva que compreende cepas de lactococcus e reduz sintomas de alergia, especialmente em bebês e crianças
SG10201405022PA (en) 2009-08-19 2014-10-30 Codexis Inc Ketoreductase polypeptides for the preparation of phenylephrine
CA2772859C (en) 2009-09-04 2015-05-26 Codexis, Inc. Variant cbh2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
DK3301208T3 (da) 2009-09-18 2020-12-14 Codexis Inc Reduceret codon-mutagenese
CA2781399C (en) 2009-11-25 2015-01-20 Codexis, Inc. Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass
PL2504017T3 (pl) 2009-11-25 2014-06-30 Codexis Inc Rekombinacyjne warianty beta-glukozydazy do wytwarzania rozpuszczalnych cukrów z biomasy celulozowej
SI2510089T1 (sl) 2009-12-08 2015-12-31 Codexis, Inc. Sinteza prazolnih spojin
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
CA2786001A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
US9040262B2 (en) 2010-05-04 2015-05-26 Codexis, Inc. Biocatalysts for ezetimibe synthesis
US20120135912A1 (en) 2010-05-10 2012-05-31 Perseid Therapeutics Llc Polypeptide inhibitors of vla4
WO2011150313A1 (en) 2010-05-28 2011-12-01 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP2582799B1 (en) 2010-06-17 2017-12-20 Codexis, Inc. Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
BR112012033361A2 (pt) 2010-06-28 2020-10-20 Codexis, Inc. acul-redutases formadoras de álcoois graxos (fars) e seus modos de uso.
CA2803952C (en) 2010-06-30 2020-03-24 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
EP2605772B1 (en) 2010-08-16 2016-06-22 Cardiome International AG Process for preparing aminocyclohexyl ether compounds
BR112013003906A2 (pt) 2010-08-20 2018-07-17 Codexis Inc uso de proteínas da família glicosideo hidrolase no processamento de celulose.
DK2649187T3 (da) 2010-12-08 2018-01-29 Codexis Inc Biokatalysatorer og fremgangsmåder til syntesen af armodafinil
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
US8663962B2 (en) 2011-03-30 2014-03-04 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
WO2013003219A1 (en) 2011-06-30 2013-01-03 Codexis, Inc. Pentose fermentation by a recombinant microorganism
WO2013028701A1 (en) 2011-08-22 2013-02-28 Codexis, Inc. Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity
WO2013036861A1 (en) 2011-09-08 2013-03-14 Codexis, Inc Biocatalysts and methods for the synthesis of substituted lactams
US20130084608A1 (en) 2011-09-30 2013-04-04 Codexis, Inc. Fungal proteases
US20130084271A1 (en) * 2011-10-03 2013-04-04 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
IN2014CN04470A (da) 2011-11-18 2015-09-04 Codexis Inc
US9611462B2 (en) 2011-12-20 2017-04-04 Codexis, Inc. Endoglucanase 1B (EG1B) variants
EP2828385B1 (en) 2012-03-23 2018-02-07 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
HUE042605T2 (hu) 2012-05-08 2019-07-29 Codexis Inc Biokatalizátorok és kémiai vegyületek hidroxilálására szolgáló eljárások
CN104428313B (zh) 2012-05-11 2017-11-17 科德克希思公司 工程化亚胺还原酶以及用于酮和胺化合物的还原胺化的方法
BR112014031026A2 (pt) 2012-06-11 2017-06-27 Codexis Inc variantes de beta-xilosidase fúngica.
CA2891482A1 (en) 2012-11-20 2014-05-30 Codexis, Inc. Pentose fermentation by a recombinant microorganism
ES2672328T3 (es) 2012-12-07 2018-06-13 Merck Sharp & Dohme Corp. Proceso de transaminación biocatalítica
US9902943B2 (en) 2012-12-21 2018-02-27 Codexis, Inc. Engineered biocatalysts and methods for synthesizing chiral amines
JP6486835B2 (ja) 2013-01-18 2019-03-20 コデクシス， インコーポレイテッド カルバペネム合成に有用な人口生体触媒
CA2902824C (en) 2013-02-28 2021-06-22 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
HUE043549T2 (hu) 2013-04-18 2019-08-28 Codexis Inc Átszerkesztett fenilalanin-ammónia-liáz polipeptidek
JP6643987B2 (ja) 2013-11-13 2020-02-12 コデクシス， インコーポレイテッド ケトン化合物およびアミン化合物の還元的アミノ化のための操作されたイミンレダクターゼおよび方法
WO2015161019A1 (en) 2014-04-16 2015-10-22 Codexis, Inc. Engineered tyrosine ammonia lyase
WO2016007623A1 (en) 2014-07-09 2016-01-14 Codexis, Inc. Novel p450-bm3 variants with improved activity
EP3224354B1 (en) 2014-11-25 2021-01-13 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
LT3237621T (lt) 2014-12-22 2023-09-25 Codexis, Inc. Žmogaus alfa-galaktozidazės variantai
DK3256577T3 (da) 2015-02-10 2020-09-14 Codexis Inc Ketoreduktase polypeptider til syntesen af chirale forbindelser
CN107531762A (zh) 2015-05-07 2018-01-02 科德克希思公司 青霉素g酰化酶
JP6691558B2 (ja) 2015-07-07 2020-04-28 コデクシス， インコーポレイテッド 改善された活性を持つ新規のｐ４５０−ｂｍ３バリアント
EP3452587B1 (en) 2016-05-05 2021-09-08 Codexis, Inc. Penicillin-g acylases
SG11201809575TA (en) 2016-06-09 2018-11-29 Codexis Inc Biocatalysts and methods for hydroxylation of chemical compounds
SG11201810998WA (en) 2016-06-15 2019-01-30 Codexis Inc Engineered beta-glucosidases and glucosylation methods
IL264686B1 (en) 2016-08-26 2024-03-01 Codexis Inc Engineered imine reductases and methods for reversible amination of ketone and amine compounds
JP7019202B2 (ja) 2017-01-05 2022-02-15 コデクシス， インコーポレイテッド ペニシリンｇアシラーゼ
CA3175070A1 (en) 2017-02-03 2018-08-09 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
SG11201906880VA (en) 2017-02-13 2019-08-27 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
BR112019022320A2 (pt) 2017-04-24 2020-05-26 Tesaro, Inc. Métodos de fabricação de niraparibe
CA3061133A1 (en) 2017-04-27 2018-11-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
JP7401902B2 (ja) 2017-05-08 2023-12-20 コデクシス， インコーポレイテッド 遺伝子操作されたリガーゼバリアント
WO2018231462A1 (en) 2017-06-14 2018-12-20 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
WO2019005337A1 (en) 2017-06-27 2019-01-03 Codexis, Inc. PENICILLIN G ACYLASES
CA3066767A1 (en) 2017-06-30 2019-01-03 Codexis, Inc. T7 rna polymerase variants
CN111032863A (zh) 2017-06-30 2020-04-17 科德克希思公司 T7 rna聚合酶变体
EP3706780A4 (en) 2017-11-07 2021-12-22 Codexis, Inc. TRANSGLUTAMINASE VARIANTS
US11015180B2 (en) 2017-12-13 2021-05-25 Codexis, Inc. Carboxyesterase polypeptides for amide coupling
BR112020011881A2 (pt) 2017-12-13 2020-11-24 Glaxosmithkline Intellectual Property Development Limited biocatalisadores de carboxiesterase
CA3102968A1 (en) 2018-06-12 2019-12-19 Codexis, Inc. Engineered tyrosine ammonia lyase
MX2021000326A (es) 2018-07-09 2021-03-25 Codexis Inc Desoxirribosa-fosfato aldolasas modificadas geneticamente.
CA3103718A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered purine nucleoside phosphorylase variant enzymes
AU2019300838A1 (en) 2018-07-09 2021-01-07 Codexis, Inc. Engineered pantothenate kinase variant enzymes
KR20210031933A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 포스포펜토뮤타제 변이체 효소
US11466259B2 (en) 2018-07-09 2022-10-11 Codexis, Inc. Engineered galactose oxidase variant enzymes
EP3820833A4 (en) 2018-07-12 2022-08-03 Codexis, Inc. MODIFIED AMMONIA-LYASE PHENYLALANINE POLYPEPTIDES
WO2020028039A1 (en) 2018-07-30 2020-02-06 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
SG11202103639SA (en) 2018-10-29 2021-05-28 Codexis Inc Engineered dna polymerase variants
SG11202105668PA (en) 2018-12-14 2021-06-29 Codexis Inc Engineered tyrosine ammonia lyase
CA3123598A1 (en) 2018-12-20 2020-06-25 Codexis, Inc. Human alpha-galactosidase variants
US20230173066A1 (en) 2019-07-23 2023-06-08 Frieslandcampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
JP2022545718A (ja) 2019-08-30 2022-10-28 コデクシス， インコーポレイテッド 操作されたリパーゼ改変体
MX2022004017A (es) 2019-10-02 2022-05-02 Abbott Diabetes Care Inc Deteccion de analitos por medio de interruptores de proteinas.
EP4077679A4 (en) 2019-12-20 2024-04-24 Codexis Inc MODIFIED ACID ALPHA-GLUCOSIDASE VARIANTS
EP4133064A2 (en) 2020-04-10 2023-02-15 Codexis, Inc. Engineered transaminase polypeptides
BR112023003643A2 (pt) 2020-08-28 2023-03-28 Codexis Inc Amilase recombinante, composição, sequência de polinucleotídeo recombinante, vetor de expressão, célula hospedeira, métodos para produzir uma amilase recombinante e para tratar e/ou prevenir os sintomas de insuficiência pancreática, composição farmacêutica para o tratamento de insuficiência pancreática, e, uso
JP2023539632A (ja) 2020-08-28 2023-09-15 コデクシス， インコーポレイテッド 操作されたプロテアーゼバリアント
EP4259772A1 (en) 2020-12-11 2023-10-18 Willow Biosciences, Inc. Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
US11898174B2 (en) 2020-12-18 2024-02-13 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
CN117120599A (zh) 2021-04-02 2023-11-24 科德克希思公司 工程化鸟苷酸激酶变体酶
CA3214972A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered adenylate kinase variant enzymes
CN117157397A (zh) 2021-04-02 2023-12-01 科德克希思公司 工程化环状GMP-AMP合酶(cGAS)变体酶
CN117222735A (zh) 2021-04-02 2023-12-12 科德克希思公司 工程化乙酸激酶变体酶
EP4377451A2 (en) 2021-07-30 2024-06-05 Willow Biosciences, Inc. Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
CA3227236A1 (en) 2021-08-19 2023-02-23 Trish Choudhary Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
ATE84680T1 (de) † 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
DD281540A5 (de) * 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ATE113441T1 (de) † 1989-10-02 1994-11-15 Sandoz Nutrition Ltd Proteinhydrolysaten.
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
DK0577903T3 (da) * 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) * 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
AU1076595A (en) † 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
AU6127896A (en) 1997-01-15
WO1997000078A1 (en) 1997-01-03
ZA965088B (en) 1997-01-22
NO321504B1 (no) 2006-05-15
PL185123B1 (pl) 2003-02-28
MX9710109A (es) 1998-10-31
NO975832L (no) 1997-12-11
ES2191103T3 (es) 2003-09-01
AU710126B2 (en) 1999-09-16
EE03424B1 (et) 2001-06-15
CN1154506C (zh) 2004-06-23
US6506380B1 (en) 2003-01-14
PL324010A1 (en) 1998-04-27
KR19990022914A (ko) 1999-03-25
SK171597A3 (en) 1998-11-04
FI952926A (fi) 1996-12-15
DK0833649T4 (da) 2009-07-20
EP0833649A1 (en) 1998-04-08
CZ291904B6 (cs) 2003-06-18
JPH11510791A (ja) 1999-09-21
EE9700339A (et) 1998-06-15
CA2224320A1 (en) 1997-01-03
CZ399797A3 (cs) 1998-06-17
EP0833649B1 (en) 2003-01-08
BR9607827A (pt) 1999-11-30
IL122577A0 (en) 1998-06-15
JP3983804B2 (ja) 2007-09-26
EP0833649B2 (en) 2009-06-03
DE69625690T2 (de) 2003-11-06
US20030113340A1 (en) 2003-06-19
BG102144A (en) 1998-12-30
MY113912A (en) 2002-06-29
NZ310478A (en) 2000-01-28
DE69625690T3 (de) 2009-12-24
KR100494741B1 (ko) 2005-09-30
ATE230606T1 (de) 2003-01-15
RO120243B1 (ro) 2005-11-30
FI104465B (fi) 2000-02-15
CA2224320C (en) 2012-03-20
US7172756B2 (en) 2007-02-06
CN1187772A (zh) 1998-07-15
ES2191103T5 (es) 2009-11-03
NO975832D0 (no) 1997-12-11
FI952926A0 (fi) 1995-06-14
HK1010081A1 (en) 1999-06-11
AR003960A1 (es) 1998-09-30
BG63153B1 (bg) 2001-05-31
SK284245B6 (sk) 2004-12-01
DE69625690D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
DK0815130T3 (da) Caseinphosphopeptid, casein indeholdende samme og fremgangsmåde til præparationen deraf
IS2321B (is) Aðferðir og blöndur til að fyrirbyggja þol gegn berkjuvíkkandi lyfjum
DK1035865T3 (da) HIV-1-Tat eller derivater deraf til profylaktisk og terapeutisk vaccination
IT1278961B1 (it) Procedimento e sistema di aferesi
NO995768D0 (no) Preparater og metoder for å inhibere fotoaldring av hud
DK0861089T3 (da) Metoder og sammensætninger til indgivelse af monomere proteiner
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
CY2010017I2 (el) Νεα πρωτεϊνη και μεθοδος παρασκευης αυτης
NO972781D0 (no) Aerosolformuleringer av peptider og proteiner
DK0881881T3 (da) Antiparasitært præparat til behandling og beskyttelse af kæledyr
DE59606267D1 (de) Mittel zur Haarbehandlung
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DK0839153T3 (da) Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
DK0961609T3 (da) Fremgangsmåde til forbedring af sundhedstilstanden af hår og hovedbund
NO976094D0 (no) Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett
DE69732436D1 (de) Sirupe sowie daraus hergestellte eine emulsion enthaltende umhuellungen
DK0805797T3 (da) Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer
NO993807L (no) Fremgangsmaate og apparatur for fremstilling av hydrolysater av krill
DK1021200T3 (da) Fremgangsmåder og præparater til behandling af rheumatoid arthritis
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
DE69629027D1 (de) Kosmetische zubereitung zur prävention und beseitigung von hautschäden